InvestorsHub Logo
Followers 1
Posts 169
Boards Moderated 0
Alias Born 02/16/2018

Re: None

Tuesday, 07/03/2018 4:11:48 PM

Tuesday, July 03, 2018 4:11:48 PM

Post# of 3329
Lieber Frederick, the termination terms you require as part of your investigation:

https://www.sec.gov/Archives/edgar/data/1517022/000119312517170662/d397855d8k.htm

Unless earlier terminated, the Agreement will expire upon the later of the expiration of all patents that claim or cover vadadustat, or expiration of data or regulatory exclusivity for vadadustat in the Territory. Vifor may terminate the Agreement its entirety upon 12 months’ prior written notice after the release of the first topline data in the vadadustat global Phase 3 program for dialysis-dependent CKD patients. Either party may, subject to a cure period, terminate the Agreement in the event of the other party’s uncured material breach. Akebia may also terminate the Agreement upon the occurrence of other events, such as for specific violations of the Agreement or if there are changes in Vifor’s relationship with FKC.

The foregoing description of the Agreement does not purport to be complete, and is qualified in its entirety by reference to the Agreement, a copy of which we expect to file with our Quarterly Report on Form 10-Q for the quarter ending June 30, 2017.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.